From Ian DeMeritt, Senior Medical Writer, Palio In what may be the first DDMAC letter to focus on Facebook, Novartis Pharmaceuticals was just warned that its use of Share Widgets on the Tasigna (nilotinib) Web site was illegal and that it misbranded the drug. Tasigna is “indicated for the treatment of chronic phase and accelerated phase [...]
ShareEntries Tagged as 'Medical Strategy'
A New Fast-Track Approval Process for Pharma?
August 6th, 2010 · No Comments · Brand Planning, Medical Strategy
From Mark McCoy, SVP, Brand Planning Director, Palio Recent developments have opened up a better, faster, cheaper route to market for new medicines. Marketers should seriously consider the medical marijuana commercialization path as an alternative to the tradition route to market via the FDA approval process. Medical Marijuana Indications Consider the status of medical marijuana [...]
ShareTags:FDA·glaucoma·medical marijuana
Take Two Tablets and Call Them in the Morning!
July 29th, 2010 · No Comments · Medical Strategy
From Steve Dubansky, MD, SVP, Medical Director, Palio After just 6 years in advertising, I’m far from an expert and claim no great insights into the “ad game.” But after 25 years of treating children with devastating diseases and supporting them and their families through incredibly stressful times, and after successfully helping to raise 5 [...]
ShareTags:advertising·agency·client·Palio
Is Our Environment Really Killing Us?
June 28th, 2010 · No Comments · Medical Strategy
From Tim Phalen, Medical Writer, Palio If you have not already read the newly released report entitled Reducing Environmental Cancer Risk: What We Can Do Now from the President’s Cancer Panel (PCP) yet, don’t do it. OK, I shouldn’t say that. You helped pay for it, after all. If you do choose to read it, don’t be [...]
ShareTags:American Cancer Society·cancer·environment·Pollution·toxins
Sunscreen, Tax and Tanning
June 18th, 2010 · 1 Comment · Medical Strategy
From Tiffany Ryan, VP, Account Services, Palio We are nearing the official start of summer, and with that people of all ages are hitting up their local drugstores for their annual supply of sunscreen. I picked up ours a few weeks back and was surprised at the lack of sunscreen with an SPF of less [...]
ShareAgency Consolidation: Is Bigger Always Better?
June 4th, 2010 · No Comments · Industry Trends, Medical Strategy
From Steve Dubansky, MD, SVP, Medical Director, Palio Let’s say you’re an oncologist with 25 years of experience in patient care, research, and teaching. You’re now working in a medium-sized pharmaceutical ad agency, and you’re the medical strategist and writer responsible for a small molecule tyrosine kinase inhibitor called pinkiemib, the first successful biologic therapy [...]
Share“What’s up, doc?” The FDA Bad Ad Program wants to know.
May 28th, 2010 · 1 Comment · Medical Strategy, advertising
From Jim Mittler, Medical Director, PhD, Palio We’ve all seen bad drug advertisements – confusing concepts, poorly written or too much copy, disconnected visual elements, etc. The FDA is now stepping up their monitoring for bad ads, but not for the creative aspects or connection to the brand. (Although, in some cases I wish there [...]
ShareSensationalism of Prescription Drug Controversies
May 21st, 2010 · No Comments · Medical Strategy
From Tim Phalen, Medical Writer, Palio Controversies surrounding prescription drugs are permanently on the media radar these days. This is not surprising given the huge and receptive audience for news about drug safety and effectiveness. The ever increasing availability of new drugs, and a populous generation reaching the age when more healthcare and prescription medications [...]
ShareWhat’s In a Name?
April 22nd, 2010 · 1 Comment · Industry Trends, Medical Strategy
From Ian DeMeritt, Senior Medical Writer, Palio “What’s in a name? That which we call a rose by any other name would smell as sweet.” – Romeo and Juliet (Act II, scene II) What if that rose didn’t have a name, yet claimed that it smelled sweet? Late last week, DDMAC issued several regulatory letters [...]
ShareCrop Yields, Green Lawns, and Cutaneous Melanoma
April 8th, 2010 · No Comments · Medical Strategy
From Steve Dubansky, MD, SVP, Medical Director, Palio “In the spring, a young man’s fancy lightly turns to thoughts of toxic pesticides.” ~Adapted from Alfred Lord Tennyson The journal Environmental Health Perspectives has just e-published a report that was as predictable as it was disturbing. Researchers have concluded that agricultural pesticides may be an important risk [...]
ShareTags:carbaryl·Environmental Health Perspectives·EPA·melanoma·pesticides·Sevin·skin cancer·toxin
